M. R. Laboratories Profile
Key Indicators
- Authorised Capital ₹ 4.50 M
as on 23-10-2024
- Paid Up Capital ₹ 3.50 M
as on 23-10-2024
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.90 Cr
as on 23-10-2024
- Satisfied Charges ₹ 1.85 Cr
as on 23-10-2024
- Revenue -50.05%
(FY 2023)
- Profit -54.65%
(FY 2023)
- Ebitda -36.38%
(FY 2023)
- Net Worth 11.47%
(FY 2023)
- Total Assets 29.39%
(FY 2023)
About M. R. Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.50 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹1.90 Cr. The company has closed loans amounting to ₹1.85 Cr, as per Ministry of Corporate Affairs (MCA) records.
Roopasi Mathi, Subbarao Matti, and Mallikarjunarao Mathi serve as directors at the Company.
- CIN/LLPIN
U24239TG2006PTC051263
- Company No.
051263
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does M. R. Laboratories Private Limited offer?
M. R. Laboratories Private Limited offers a wide range of products and services, including API (Active Pharmaceutical Ingredients), Pharmaceutical Pellets, Plastic Granules.
Who are the key members and board of directors at M. R. Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Roopasi Mathi  | Director | 15-Apr-2016 | Current |
| Subbarao Matti | Director | 26-Sep-2006 | Current |
| Mallikarjunarao Mathi | Director | 26-Sep-2006 | Current |
Financial Performance of M. R. Laboratories.
M. R. Laboratories Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 50.05% decrease. The company also saw a substantial fall in profitability, with a 54.65% decrease in profit. The company's net worth Soared by an impressive increase of 11.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M. R. Laboratories?
In 2023, M. R. Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
M.R. Formulations Private LimitedActive 8 years 11 monthsRoopasi Mathi and Mallikarjunarao Mathi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Mar 2023 | ₹1.70 Cr | Open |
Others Creation Date: 16 Nov 2022 | ₹1.98 M | Open |
Bank Of Baroda Creation Date: 12 Dec 2011 | ₹1.55 Cr | Satisfied |
How Many Employees Work at M. R. Laboratories?
Unlock and access historical data on people associated with M. R. Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M. R. Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M. R. Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
